Works matching IS 15268209 AND DT 2013 AND VI 13 AND IP 4
Results: 14
Clinicopathological features among patients with advanced human epidermal growth factor-2-positive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a meta-analysis.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Current status of anti-human epidermal growth factor receptor 2 therapies: predicting and overcoming herceptin resistance.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 299, doi. 10.1016/j.clbc.2013.02.004
- By:
- Publication type:
- Article
Comparison of Two Radiotherapeutic Hypofractionated Schedules in the Application of Tumor Bed Boost.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 292, doi. 10.1016/j.clbc.2013.02.007
- By:
- Publication type:
- Article
Sentinel Lymph Node Biopsy in Contralateral Prophylactic Mastectomy: Are We Overtreating? Experience at a Tertiary Care Hospital.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 287, doi. 10.1016/j.clbc.2013.02.006
- By:
- Publication type:
- Article
Intraductal Therapy of Ductal Carcinoma In Situ: A Presurgery Study.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 280, doi. 10.1016/j.clbc.2013.02.002
- By:
- Publication type:
- Article
Fluorine- 18 Fluorodeoxyglucose Positron Emission Tomography--Computed Tomography in Monitoring the Response of Breast Cancer to Neoadjuvant Chemotherapy: A Meta--Analysis.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 271, doi. 10.1016/j.clbc.2013.02.003
- By:
- Publication type:
- Article
Negligible Nuclear FOXP3 Expression in Breast Cancer Epithelial Cells Compared With FOXP3-Positive T Cells.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 264, doi. 10.1016/j.clbc.2013.02.009
- By:
- Publication type:
- Article
Prognostic Role of Human Epidermal Growth Factor Receptor 2 Status in Premenopausal Early Breast Cancer Treated With Adjuvant Tamoxifen.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 247, doi. 10.1016/j.clbc.2013.02.005
- By:
- Publication type:
- Article
Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 239, doi. 10.1016/j.clbc.2013.02.008
- By:
- Publication type:
- Article
Correlation Between Nottingham Prognostic Index and Adjuvant! Online Prognostic Tools in Patients With Early-Stage Breast Cancer in Mid-Western Ireland.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 233, doi. 10.1016/j.clbc.2013.02.011
- By:
- Publication type:
- Article
Current Status of Anti--Human Epidermal Growth Factor Receptor 2 Therapies: Predicting and Overcoming Herceptin Resistance.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 223, doi. 10.1016/j.clbc.2013.04.001
- By:
- Publication type:
- Article
Clinicopathological Features Among Patients With Advanced Human Epidermal Growth Factor--2-Positive Breast Cancer With Prolonged Clinical Benefit to First-Line Trastuzumab-Based Therapy: A Retrospective Cohort Study.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 254, doi. 10.1016/j.clbc.2013.02.010
- By:
- Publication type:
- Article